PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/2906/11/16
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Novo Nordisk
A CMRO paper (ABPI-funded) assessed whether results of company-sponsored trials for EMA-approved 2013 medicines were disclosed within 12 months of the later of first regulatory approval or trial co…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2893/11/16
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
GE Healthcare
An anonymous, non-contactable complainant alleged GE Healthcare promoted Vizamyl (18F flutemetamol) and/or unlicensed 18F flutemetamol injection to UK PET centres and at the EANM congress (Barcelon…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2890/11/16
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Novo Nordisk websites
A health professional complained about Novo Nordisk’s UK corporate website and a separate professional resource website.Concerns included: patients shown with photos and full names; diabetes pati…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2903/11/16
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Novo Nordisk
The PMCPA Director initiated a complaint after a CMRO publication (25 Nov 2016) assessed disclosure of results for company-sponsored trials linked to new medicines approved by EMA in 2013.The publi…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2819/2/16
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Otsuka
A general practitioner complained that Jinarc (tolvaptan) patient support materials portrayed the medicine as a treatment for ADPKD, amounting to advertising to the public and risking raised patien…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2827/3/16
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Novartis
An anonymous hepatologist complained about a Novartis tweet relating to liver disease.The complaint was received on 10 March 2016.The case was completed on 13 April 2016.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2881/10/16
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Shire
An anonymous complainant (non-contactable) alleged there was a Shire video on a public website.The complaint was received on 11 October 2016.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2846/5/16
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Janssen
Janssen voluntarily admitted that a first-line sales manager did not take the required ABPI representatives examination within one year of starting the role.The employee moved into the sales manage…
Clauses: 11.2
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2834/4/16
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Takeda v Amdipharm Mercury
Takeda complained about a promotional email for Lutrate (leuprorelin acetate depot injection) (ref AMCo/LUT/1115/0027) sent by Amdipharm Mercury Company Ltd (AMCo) to health professionals and NHS b…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2832/4/16
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Baxter
Baxter Healthcare made a voluntary admission that one of its representatives had not taken the required representatives’ examinations within one year of commencing their role.A review of Baxter�…
Clauses: 11.1
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2871/8/16
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Janssen
Janssen-Cilag voluntarily admitted that a Crohn’s disease “awareness” campaign initiated/approved by the Janssen European team was used in the UK and amounted to pre-licence promotion.The cam…
Clauses: 3.2,9.1
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2870/8/16
Social Media & Digital Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Janssen
Janssen-Cilag Ltd placed four two-page Trevicta (paliperidone palmitate 3 monthly) journal advertisements during July and August 2016.The prescribing information (PI) appeared overleaf on the secon…
Clauses: 4.3,4.9
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2854/7/16
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Boehringer Ingelheim voluntary admission
Boehringer Ingelheim conducted a review of promotional materials and identified that a number of hard copy promotional “job bags” had not received an extra signatory signature to confirm the ce…
Clauses: 14.1
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2853/6/16
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous complainant raised concerns about a GlaxoSmithKline (GSK) advertisement on Telegraph Online (28 June 2016).The ad was understood to be a 30-second video: “How we are tackling malaria…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2851/6/16
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Novo Nordisk
An anonymous, contactable complainant alleged Tresiba (insulin degludec) was promoted to the public via a LinkedIn posting.The LinkedIn communication named a Novo Nordisk employee and included cont…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2849/6/16
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Lilly
A consultant oncologist and a pharmacist complained about a medically significant error in the 8th edition of the Handbook of Systemic Treatments for Cancer (UKONC00326, Feb 2014) relating to Alimt…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2845/5/16
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Swedish Orphan Biovitrum
CSL Behring complained about a “Sobi Charity Ball” and a public advertisement/invitation posted on Sobi’s and a charity’s website.The advert stated a £65 ticket price including arrival dri…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2924/12/16
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Lincoln Medical website
An anonymous, non-contactable pharmacist complained about statements on Lincoln Medical’s website.The ‘About us’ page (and similar wording on a ‘Products’ page) named prescription only me…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2921/12/16
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Grünenthal
Grünenthal voluntarily admitted that a video certified for internal use only about Palexia SR (tapentadol prolonged release) was uploaded to YouTube without the company’s knowledge.The video had…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2915/12/16
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Janssen
An anonymous, non-contactable complainant (self-described health professional) complained about the venue for a forthcoming promotional meeting for Invokana (canagliflozin) in type 2 diabetes.The i…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2911/11/16
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Galen
An anonymous, non-contactable complainant alleged Galen’s promotion of Laxido (macrogol plus electrolytes) at a Scottish Prescribers Association meeting involved misleading cost-saving comparison…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2892/11/16
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Galen
An anonymous, non-contactable complainant (appearing to work in a CCG) complained about Galen’s Trustsaver website promoting potential NHS savings linked to Galen’s laxative Laxido (macrogol pl…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2878/10/16
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Meda
A member of the public complained about a Facebook post by a mother of a child with life-threatening allergies.The post showed a photo of two EpiPens and text supporting the “#carrytwocampaign”…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2868/8/16
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Sanofi Genzyme
Janssen complained that at the EULAR Congress of Rheumatology (London, June 2016) Sanofi Genzyme promoted its forthcoming IL-6 receptor blocker, sarilumab, before it had a marketing authorization.T…
Clauses: 9.1
2016 🔒 Subscribe
← Prev 19 20 21 22 23 24 25 Next → Page 22 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews